Sertraline for the Treatment of Depression in Alzheimer Disease: Genetic Influences

OBJECTIVE: To assess the potential for genetic influences on sertraline treatment efficacy for depression of Alzheimer disease (dAD). Four functional genetic variants were studied: 2 serotonin receptors (HTR2A-T102C and HTR2C-Cys23Ser), the serotonin transporter (5HTT-LPR), and brain-derived neurotr...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Peters, Matthew E., Vaidya, Vijay, Drye, Lea T., Rosenberg, Paul B., Martin, Barbara K., Porsteinsson, Anton P., Frangakis, Constantine E., Mintzer, Jacobo, Weintraub, Daniel, Schneider, Lon S., Rabins, Peter V., Munro, Cynthia A., Meinert, Curtis L., Lyketsos, Constantine G., Dimitri, Avramopoulos
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3535452/
https://ncbi.nlm.nih.gov/pubmed/22228829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0891988711422527
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items